214 related articles for article (PubMed ID: 16205723)
1. Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension.
Guilluy C; Sauzeau V; Rolli-Derkinderen M; Guérin P; Sagan C; Pacaud P; Loirand G
Br J Pharmacol; 2005 Dec; 146(7):1010-8. PubMed ID: 16205723
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
Li FH; Xia W; Li AW; Zhao CF; Sun RP
Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
[TBL] [Abstract][Full Text] [Related]
3. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
Li B; Yang L; Shen J; Wang C; Jiang Z
Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
[TBL] [Abstract][Full Text] [Related]
4. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
[TBL] [Abstract][Full Text] [Related]
5. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.
Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ
Br J Pharmacol; 2010 Jun; 160(4):971-86. PubMed ID: 20590592
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil alters calcium signaling and vascular tone in pulmonary arteries from chronically hypoxic rats.
Pauvert O; Bonnet S; Rousseau E; Marthan R; Savineau JP
Am J Physiol Lung Cell Mol Physiol; 2004 Sep; 287(3):L577-83. PubMed ID: 15155272
[TBL] [Abstract][Full Text] [Related]
7. Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathway.
Chau VQ; Salloum FN; Hoke NN; Abbate A; Kukreja RC
Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2272-9. PubMed ID: 21398594
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin and sildenafil combine to attenuate pulmonary hypertension.
Zhao L; Sebkhi A; Ali O; Wojciak-Stothard B; Mamanova L; Yang Q; Wharton J; Wilkins MR
Eur Respir J; 2009 Oct; 34(4):948-57. PubMed ID: 19797670
[TBL] [Abstract][Full Text] [Related]
9. Rho kinase mediates right ventricular systolic dysfunction in rats with chronic neonatal pulmonary hypertension.
Gosal K; Dunlop K; Dhaliwal R; Ivanovska J; Kantores C; Desjardins JF; Connelly KA; McNamara PJ; Jain A; Jankov RP
Am J Respir Cell Mol Biol; 2015 Jun; 52(6):717-27. PubMed ID: 25337652
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with fasudil and sildenafil ameliorates monocrotaline-induced pulmonary hypertension and survival in rats.
Elias-Al-Mamun M; Satoh K; Tanaka S; Shimizu T; Nergui S; Miyata S; Fukumoto Y; Shimokawa H
Circ J; 2014; 78(4):967-76. PubMed ID: 24553194
[TBL] [Abstract][Full Text] [Related]
11. The beneficial impact of fasudil and sildenafil on monocrotaline-induced pulmonary hypertension in rats: a hemodynamic and biochemical study.
Jasińska-Stroschein M; Owczarek J; Łuczak A; Orszulak-Michalak D
Pharmacology; 2013; 91(3-4):178-84. PubMed ID: 23428587
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation.
Morelli A; Chavalmane AK; Filippi S; Fibbi B; Silvestrini E; Sarchielli E; Zhang XH; Vignozzi L; Vannelli GB; Forti G; Maggi M
J Sex Med; 2009 Jan; 6(1):91-106. PubMed ID: 19170840
[TBL] [Abstract][Full Text] [Related]
13. Cellular regulation of basal tone in internal anal sphincter smooth muscle by RhoA/ROCK.
Patel CA; Rattan S
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1747-56. PubMed ID: 17379756
[TBL] [Abstract][Full Text] [Related]
14. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
Li F; Xia W; Li A; Zhao C; Sun R
Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of phosphodiesterase-5 inhibitors on hypoxic pulmonary vasoconstriction and pulmonary artery cytokine expression.
Tsai BM; Turrentine MW; Sheridan BC; Wang M; Fiore AC; Brown JW; Meldrum DR
Ann Thorac Surg; 2006 Jan; 81(1):272-8. PubMed ID: 16368379
[TBL] [Abstract][Full Text] [Related]
16. Sildenafil prevents change in RhoA expression induced by chronic hypoxia in rat pulmonary artery.
Sauzeau V; Rolli-Derkinderen M; Lehoux S; Loirand G; Pacaud P
Circ Res; 2003 Oct; 93(7):630-7. PubMed ID: 12946946
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cGMP phosphodiesterase 5 suppresses serotonin signalling in pulmonary artery smooth muscles cells.
Li M; Sun X; Li Z; Liu Y
Pharmacol Res; 2009 May; 59(5):312-8. PubMed ID: 19416631
[TBL] [Abstract][Full Text] [Related]
18. PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation.
Hemnes AR; Zaiman A; Champion HC
Am J Physiol Lung Cell Mol Physiol; 2008 Jan; 294(1):L24-33. PubMed ID: 17965319
[TBL] [Abstract][Full Text] [Related]
19. [Expression and activity of RhoA/Rho kinase in remodeling of high blood flow pulmonary vessels.].
Li FH; Xia W; Sun RP
Zhonghua Er Ke Za Zhi; 2007 May; 45(5):387-92. PubMed ID: 17697629
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension.
Sebkhi A; Strange JW; Phillips SC; Wharton J; Wilkins MR
Circulation; 2003 Jul; 107(25):3230-5. PubMed ID: 12796132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
